Aurora Cannabis Inc (FRA:21P)
€ 4.476 0.082 (1.87%) Market Cap: 243.66 Mil Enterprise Value: 254.48 Mil PE Ratio: 0 PB Ratio: 0.67 GF Score: 64/100

Q3 2024 Aurora Cannabis Inc Earnings Call Transcript

Feb 08, 2024 / 01:00PM GMT
Release Date Price: €3.8 (-1.53%)
Operator

Yes, greetings, and welcome to the Aurora Cannabis Third Quarter 2024 Results Conference Call. All participants will be in a listen only mode. And a question and answer session will follow the formal presentation. This conference call is being recorded today, Thursday, February 8, 2024. I would now like to turn the conference over to your host Ananth Krishnan, Vice President, Corporate Development and Strategy. Please go ahead.

Ananth Krishnan
Aurora Cannabis Inc. - VP of Capital Markets & IR

Thank you, operator. Hello, everyone, and thank you for joining us on the line with me are Miguel Martin, CEO. Glen Ibbott, CFO. This morning, our Board issued a news release announcing our fiscal 2024 third quarter financial results and a separate news release announcing the acquisition of MedReleaf Australia.

These separate news releases and our fiscal Q3 2024 financial statements and MD&A are available on our IR website and can also be accessed by a CDR plus and Edgar. In addition, you will find a supplemental information deck on our IR website.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot